Name: Latest research reports of Piramal Pharma Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Piramal Pharma Ltd.
Rating: 5
Author: Motilal Oswal

Piramal Pharma Ltd.

NSE: PPLPHARMA | BSE: 543635 | ISIN: INE0DK501011 | Industry: Pharmaceuticals
| Falling Comet

142.9500 -0.82 (-0.57%)

NSE Apr 09, 2026 15:49 PM

37.43% Fall from 52W High

Volume: 1.6M

Piramal Pharma Ltd.

25 Sep 2024

142.95

-0.57%

Geared to drive robust operating leverage across segments

Buy: Piramal Pharma Ltd.

Target

Motilal Oswal

PIRPHARM is well-positioned to offer differentiated services at the product development and commercial manufacturing stage in the CDMO segment.

Piramal Pharma has lost -35.48% in the last 1 Year